These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2586 related items for PubMed ID: 29297205

  • 1. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN.
    Cochrane Database Syst Rev; 2018 Jan 03; 1(1):CD010908. PubMed ID: 29297205
    [Abstract] [Full Text] [Related]

  • 2. Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis.
    Barnes H, Ghazipura M, Herman D, Macrea M, Knight SL, Silver RM, Montesi SB, Raghu G, Hossain T.
    Ann Am Thorac Soc; 2024 Jan 03; 21(1):122-135. PubMed ID: 37772975
    [Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H, Brown Z, Burns A, Williams T.
    Cochrane Database Syst Rev; 2019 Jan 31; 1(1):CD012621. PubMed ID: 30701543
    [Abstract] [Full Text] [Related]

  • 4. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial.
    Maher TM, Tudor VA, Saunders P, Gibbons MA, Fletcher SV, Denton CP, Hoyles RK, Parfrey H, Renzoni EA, Kokosi M, Wells AU, Ashby D, Szigeti M, Molyneaux PL, RECITAL Investigators.
    Lancet Respir Med; 2023 Jan 31; 11(1):45-54. PubMed ID: 36375479
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A, RELIEF investigators.
    Lancet Respir Med; 2021 May 31; 9(5):476-486. PubMed ID: 33798455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.
    Roofeh D, Barratt SL, Wells AU, Kawano-Dourado L, Tashkin D, Strand V, Seibold J, Proudman S, Brown KK, Dellaripa PF, Doyle T, Leonard T, Matteson EL, Oddis CV, Solomon JJ, Sparks JA, Vassallo R, Maxwell L, Beaton D, Christensen R, Townsend W, Khanna D.
    Semin Arthritis Rheum; 2021 Dec 31; 51(6):1331-1341. PubMed ID: 34493396
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of oral versus intravenous cyclophosphamide in treatment of connective tissue disease-related interstitial lung disease.
    Feng Y, Chen J, Yang X, Liu J, Cao X, Zhang Y, Wu Z.
    Int J Rheum Dis; 2024 Oct 31; 27(10):e15354. PubMed ID: 39352049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.
    Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM.
    J Rheumatol; 2019 Oct 31; 46(10):1316-1325. PubMed ID: 30770517
    [Abstract] [Full Text] [Related]

  • 18. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H, McDonald J, Smallwood N, Manser R.
    Cochrane Database Syst Rev; 2016 Mar 31; 3(3):CD011008. PubMed ID: 27030166
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab in connective tissue disease-associated interstitial lung disease.
    Duarte AC, Cordeiro A, Fernandes BM, Bernardes M, Martins P, Cordeiro I, Santiago T, Seixas MI, Ribeiro AR, Santos MJ.
    Clin Rheumatol; 2019 Jul 31; 38(7):2001-2009. PubMed ID: 31016581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 130.